InvestorsHub Logo
Followers 2
Posts 353
Boards Moderated 0
Alias Born 06/22/2018

Re: None

Friday, 05/12/2023 10:08:34 AM

Friday, May 12, 2023 10:08:34 AM

Post# of 36578
Anyone see this new disclaimer added in this PR?

“There can be no assurance that the Company will proceed with the clinical development and regulatory approvals of Bucillamine for COVID-19 in the U.S. and internationally.”